StoxGud Sign in
60

Aarey Drugs & Pharmaceuticals Limited

NSE: AAREYDRUGS · Unclassified

₹107.72-1.52%06 Nov 2026

Ask the data

Instant answers about Aarey Drugs & Pharmaceuticals Limited — computed from its filings, no language model
Market cap₹307 cr
Current price₹107.72
High / Low₹114 / ₹51
P/E62.8
P/B2.04
Book value₹52.9
ROE3.2%
ROCE4.9%
Debt / equity0.33
Dividend yield—
EPS (TTM)₹1.72
Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin
showing latest 6 of 18 periods
FY09†FY10†FY11†FY12†FY13†FY14†FY15†FY16†FY17†FY18†FY19†FY20†FY21†FY22FY23FY24FY25FY26
Revenue27.546.665.9131.2172.6201.3216.0249.2398.4349.4354.8300.1332.9492.762.5395.6473.9472.3
EBITDA—————————7.67.93.24.611.31.54.52.27.2
Operating margin—————————2.2%2.2%1.1%1.4%2.3%2.4%1.1%0.5%1.5%
Interest—————————1.92.21.82.42.00.64.44.05.0
Depreciation—————————0.71.00.90.92.00.71.71.92.9
Profit before tax1.11.21.00.40.91.41.41.88.08.29.07.28.310.00.85.36.15.4
Tax0.20.00.10.10.20.30.30.52.12.02.41.42.02.50.20.72.11.4
Net profit0.91.10.80.30.71.11.11.35.96.26.55.86.37.50.54.74.04.0
EPS ₹—————————————2.720.191.843.271.39
Operating cash flow—————————————18.6-39.17.99.710.1
Capex—————————————-2.21.00.00.012.4
Dividend paid—————————————0.00.00.00.00.0
Total assets——————————————291.3305.0238.3297.2
Equity——————————————117.4132.8138.5150.4

Quarterly performance

last 76 quarters · ₹ crore
showing latest 8 of 76 periods
SEP '07†DEC '07†MAR '08†JUN '08†SEP '08†DEC '08†MAR '09†JUN '09†SEP '09†DEC '09†MAR '10†JUN '10†SEP '10†DEC '10†MAR '11†JUN '11†SEP '11†DEC '11†MAR '12†JUN '12†SEP '12†DEC '12†MAR '13†JUN '13†SEP '13†DEC '13†MAR '14†JUN '14†SEP '14†DEC '14†MAR '15†JUN '15†SEP '15†DEC '15†MAR '16†JUN '16†SEP '16†DEC '16†MAR '17†JUN '17†SEP '17†DEC '17†MAR '18†JUN '18†SEP '18†DEC '18†MAR '19†JUN '19†SEP '19†DEC '19†MAR '20†JUN '20†SEP '20†DEC '20†MAR '21†JUN '21SEP '21DEC '21MAR '22JUN '22SEP '22DEC '22MAR '23JUN '23SEP '23DEC '23MAR '24JUN '24SEP '24DEC '24MAR '25JUN '25SEP '25DEC '25MAR '26JUN '26
Revenue4.18.58.97.06.08.36.37.07.012.120.69.613.115.327.928.131.532.439.234.640.548.349.347.357.558.438.034.649.052.879.642.633.264.5108.995.483.296.9122.973.869.289.6116.867.471.678.4137.366.263.659.6110.725.249.879.7178.297.5134.7140.3120.2117.376.362.5158.251.057.876.5210.3126.9105.1133.8108.1102.284.296.4189.544.6
Operating profit——————————————————————————————————————3.91.51.92.22.01.22.22.02.51.31.11.3-0.51.50.30.52.42.93.43.11.9-0.64.31.5-2.21.31.92.7-1.41.23.72.2-4.81.72.6-1.54.31.3
Operating margin——————————————————————————————————————3.2%2.0%2.7%2.5%1.7%1.8%3.1%2.5%1.8%1.9%1.8%2.2%-0.4%6.0%0.6%0.6%1.3%3.0%2.5%2.2%1.5%-0.5%5.6%2.4%-1.4%2.6%3.2%3.5%-0.7%0.9%3.5%1.6%-4.5%1.7%3.1%-1.6%2.3%3.0%
Other income—————————0.00.1—0.1—0.10.2——-0.1—0.10.00.20.30.10.11.00.00.10.12.40.71.01.10.30.80.80.80.90.90.20.31.71.20.50.71.81.50.90.83.40.72.52.11.60.70.80.11.12.4-0.90.55.50.70.80.35.11.60.00.77.51.60.84.2-0.41.7
Interest——————————————————————————————————————1.00.30.30.60.60.20.41.00.70.40.50.50.40.50.80.60.60.50.60.50.60.60.60.71.00.91.31.11.11.01.50.92.51.01.30.91.81.7
Depreciation——————————————————————————————————————0.40.20.10.10.20.20.20.20.50.20.30.20.10.20.20.20.20.40.50.50.40.40.40.60.20.40.40.50.40.50.50.6-1.40.50.70.80.80.8
Profit before tax0.10.40.40.20.20.30.40.20.20.30.50.40.20.20.20.40.20.2-0.50.40.50.3-0.30.21.00.2-0.10.60.30.10.40.60.50.20.61.11.71.83.41.91.61.82.82.12.11.63.22.11.31.42.41.61.91.73.22.73.12.22.00.82.30.82.60.71.01.52.11.31.81.41.61.71.50.91.30.5
Tax0.00.00.10.00.00.00.20.00.00.00.00.00.10.00.00.00.10.0-0.00.00.00.00.20.00.10.00.10.00.00.00.30.00.00.00.50.00.00.02.10.00.00.02.00.00.00.02.40.00.00.01.40.20.00.01.80.20.30.21.80.0-0.20.21.30.00.20.4-0.00.10.10.71.10.40.5-0.3-0.3-0.5
Net profit0.10.40.30.20.20.30.10.20.20.30.40.40.10.20.20.40.10.2-0.50.40.50.3-0.50.20.80.2-0.20.60.30.10.10.60.50.20.01.11.71.81.31.91.61.80.82.12.11.60.72.11.31.41.01.41.91.71.42.52.81.90.20.82.50.51.40.70.81.02.11.21.60.70.51.41.01.31.61.0
EPS ₹0.300.720.560.470.410.640.290.500.420.540.850.720.150.400.390.780.160.51-0.330.300.290.17-0.320.150.480.15-0.150.340.160.090.050.360.270.120.020.650.961.000.741.050.820.900.350.900.920.660.310.900.550.600.430.580.790.730.601.071.220.770.300.320.830.190.140.290.310.400.770.881.140.260.040.480.720.200.550.36
Revenue YoY————45.9%-2.5%-29.6%0.6%15.6%46.2%227.2%37.1%89.1%26.3%35.6%193.3%140.0%111.4%40.7%23.0%28.3%49.1%25.7%36.9%42.2%21.1%-22.8%-26.8%-14.9%-9.6%109.2%23.0%-32.2%22.0%36.9%123.9%150.5%50.3%12.9%-22.6%-16.9%-7.5%-5.0%-8.7%3.6%-12.4%17.5%-1.7%-11.3%-24.0%-19.4%-61.9%-21.6%33.5%61.0%286.7%170.3%76.1%-32.5%20.3%-43.4%-55.5%31.5%-56.6%-24.2%22.4%33.0%149.0%81.8%74.9%-48.6%-19.5%-20.0%-27.9%75.3%-56.3%
Profit YoY————33.3%-11.1%-46.4%8.7%5.0%-15.6%180.0%44.0%-61.9%-25.9%-54.8%8.3%0.0%25.0%-342.1%7.7%525.0%16.0%—-42.9%62.0%-13.8%—141.7%-66.7%-40.0%—3.4%66.7%33.3%-50.0%83.3%273.3%780.0%3250.0%73.6%-1.8%2.3%-38.8%9.9%30.3%-13.9%-9.8%0.0%-39.5%-9.7%35.1%-35.2%42.3%21.4%41.0%84.6%53.5%14.7%-83.7%-68.1%-10.9%-74.9%487.0%-10.0%-69.2%108.2%59.3%72.2%105.1%-29.4%-78.1%10.5%-36.3%77.8%231.9%-25.5%

Returns & margins

trailing-twelve-month, per quarter
showing latest 8 of 73 periods
JUN '08SEP '08DEC '08MAR '09JUN '09SEP '09DEC '09MAR '10JUN '10SEP '10DEC '10MAR '11JUN '11SEP '11DEC '11MAR '12JUN '12SEP '12DEC '12MAR '13JUN '13SEP '13DEC '13MAR '14JUN '14SEP '14DEC '14MAR '15JUN '15SEP '15DEC '15MAR '16JUN '16SEP '16DEC '16MAR '17JUN '17SEP '17DEC '17MAR '18JUN '18SEP '18DEC '18MAR '19JUN '19SEP '19DEC '19MAR '20JUN '20SEP '20DEC '20MAR '21JUN '21SEP '21DEC '21MAR '22JUN '22SEP '22DEC '22MAR '23JUN '23SEP '23DEC '23MAR '24JUN '24SEP '24DEC '24MAR '25JUN '25SEP '25DEC '25MAR '26JUN '26
ROE—————————————————————————————————————————————————————————4.7%3.5%4.4%4.3%2.8%3.3%3.5%3.9%4.4%4.2%2.9%3.0%2.4%2.8%3.5%3.2%
ROCE—————————————————————————————————————————————————————————6.8%5.9%6.0%6.2%5.8%6.4%5.9%6.3%6.5%6.4%6.9%7.2%6.0%5.7%5.2%4.9%
Net margin3.6%3.5%3.4%3.3%3.3%3.3%2.7%2.5%2.6%2.0%1.8%1.3%1.0%0.8%0.8%0.2%0.2%0.5%0.5%0.4%0.3%0.4%0.4%0.5%0.7%0.5%0.4%0.5%0.5%0.6%0.6%0.5%0.6%0.9%1.2%1.5%1.8%1.8%1.9%1.8%1.9%2.0%2.0%1.8%1.8%1.6%1.7%1.9%2.0%2.3%2.2%1.9%1.8%1.7%1.6%1.5%1.1%1.2%1.1%1.2%1.5%1.0%1.1%1.2%1.1%1.2%1.0%0.9%0.9%0.8%1.1%1.1%1.2%
EBITDA margin——————————————————————————————————————2.7%2.2%2.1%2.2%2.2%2.2%2.2%2.0%1.9%1.1%1.3%1.1%0.7%1.4%1.5%1.9%2.1%2.3%1.5%1.9%1.9%0.7%1.4%0.8%1.1%1.1%0.9%1.2%1.0%0.5%0.6%0.4%-0.5%1.5%1.6%
Debt / equity—————————————————————————————————————————————————————————0.210.210.320.320.310.310.240.240.290.290.250.250.340.340.330.33
Interest coverage——————————————————————————————————————4.895.365.825.834.945.034.624.234.915.144.724.394.364.404.885.776.285.604.584.263.383.273.002.322.382.222.342.432.472.042.102.102.012.081.75
Asset turnover—————————————————————————————————————————————————————————1.991.651.421.191.411.471.301.551.892.101.991.891.461.331.591.40

Balance sheet

equity vs borrowings over time · ₹ crore
showing latest 6 of 8 periods
SEP '22MAR '23SEP '23MAR '24SEP '24MAR '25SEP '25MAR '26
Share capital25.425.425.428.128.128.128.428.4
Other equity / reserves91.292.093.5104.7107.5110.4120.4122.0
Total equity116.6117.4118.9132.8135.6138.5148.8150.4
Borrowings24.237.737.431.438.634.950.850.0
Current liabilities89.5168.1109.8168.20.596.9142.8145.1
Non-current liabilities22.45.85.24.0138.42.92.31.8
Total assets228.4291.3234.0305.0274.5238.3294.0297.2
Property, plant & equipment14.313.913.214.713.016.225.125.8
Capital work-in-progress—0.00.0—0.00.0—0.0
Investments0.40.0109.50.00.00.00.02.1
Inventories20.528.822.434.729.845.539.141.5
Receivables132.8189.80.0184.5142.4129.6122.3129.7
Cash & equivalents0.10.71.21.61.51.57.21.4

Cash flow

annual · ₹ crore · line = free cash flow
FY22FY23FY24FY25FY26
Cash from operations18.6-39.17.99.710.1
Cash from investing24.411.2-7.3-5.9-12.4
Cash from financing4.4-22.54.1-3.82.2
Capex-2.21.00.00.012.4
Free cash flow20.8-40.17.99.7-2.3
Dividends paid0.00.00.00.00.0

Where the assets sit

Mar '26 · ₹ crore
Fixed assets (PPE)
₹25.8 cr9%
Investments
₹2.1 cr1%
Inventories
₹41.5 cr14%
Receivables
₹129.7 cr44%
Cash & equivalents
₹1.4 cr0%
Other assets
₹96.8 cr33%

Peer comparison

largest in Unclassified · this company in bold
CompanyMarket cap ₹crPriceP/EP/BROE
Avantel Limited36,86,04,549138.69—1059360.680.0%
Ducol Organics And Colours Limited19,55,275120.00—20089.130.0%
Jio Platforms Limited12,57,1811,406.40—3.57—
SBI Funds Management Limited1,01,750499.55———
Tamilnadu Telecommunication Limited91,3149.93———
Manipal Health Enterprises Limited76,294646.70———
INDO-MIM Limited59,0421,219.50———
AvenuesAI Limited45,138129.25153.69.516.2%
Dhoot Transmission Limited32,7611,601.60—8.11—
3M India Limited31,07127,570.0053.817.5732.7%
Aarey Drugs & Pharmaceuticals Limited307107.7262.82.043.2%

StoxGud checklist: Neutral setup · 6/10

  • Price above 50-day average
  • Price above 200-day average
  • 50-day average above 200-day (uptrend)
  • RSI in healthy 40–70 zone
  • Positive 1-year return
  • Return on equity above 15%
  • Debt to equity below 1
  • Revenue growing year on year
  • Net profit margin above 10%
  • P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-1.0%
6 months+22.4%
1 year+15.7%
3Y CAGR+34.8%
5Y CAGR+22.8%
10Y CAGR—
50-day avg₹102.17
200-day avg₹83.22
RSI (14)43

FAQs

What is the share price of Aarey Drugs & Pharmaceuticals Limited?

Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) closed at ₹107.72 on NSE on 06 Nov 2026.

What is the market cap of Aarey Drugs & Pharmaceuticals Limited?

₹307 crore at the latest close.

What is the P/E ratio of Aarey Drugs & Pharmaceuticals Limited?

62.8, on trailing-twelve-month earnings from its filings.

How fast is Aarey Drugs & Pharmaceuticals Limited growing?

Aarey Drugs & Pharmaceuticals Limited: revenue has compounded at 96.3% a year over three years; net profit at 100.8% a year. Latest-quarter revenue is down 56.3% year on year, profit down 25.5%.

How profitable is Aarey Drugs & Pharmaceuticals Limited?

On a trailing-twelve-month basis return on equity is 3.2%, return on capital employed 4.9%, operating margin 1.6%, net margin 1.2%.

How much debt does Aarey Drugs & Pharmaceuticals Limited have?

Aarey Drugs & Pharmaceuticals Limited is lightly geared: debt to equity is 0.33 with borrowings of ₹50 cr against cash of ₹1 cr (balance sheet of 2026-03-31). Operating profit covers interest 1.7 times.

Financials parsed from Aarey Drugs & Pharmaceuticals Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Quarterly from SEP '07, annual from FY09, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). † = the company's standalone results as published on BSE, used for quarters before JUN '21 (full years marked † are summed from them); cross-checked against the NSE filings where both exist. Information only, not investment advice.